CRO

The CRO (Contract Research Organization) theme includes providers of outsourced R&D and clinical services to biopharma and med‑tech sponsors. Core tracks span preclinical discovery and toxicology, clinical trial operations (Phases I–IV), site management/SMO, data management and biostatistics, central labs and imaging, regulatory/medical writing and pharmacovigilance, eClinical platforms, and real‑world evidence.The sector's total market cap is 102.92 billion USD, with a 24h change of -0.49%. Among 5 constituents, 3 are up (60.00%) and 2 are down (40.00%). The top gainer is Quest Diagnostics Inc. (DGX), with a 24h increase of +0.64%.Momentum firm with leaders in control and mixed breadth. Near term, follow quality names; medium term, pace exposure with earnings clarity and regulatory/interest‑rate backdrop.